Skip to content

Mesenchymal stem cells alleviate primary Sjogren syndrome by inhibit B cell activation through down-regulate BAFF

Mesenchymal stem cells alleviate primary Sjogren syndrome by inhibit B cell activation through down-regulate BAFF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RPC-17013171
Enrollment
Unknown
Registered
2017-10-30
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Sjogren Syndrome

Interventions

control:none

Sponsors

Shanghai sixth people's hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who meet the criteria of primary sjogren syndrome.;Inclusion criteria: The patients who meet the criteria of primary sjogren syndrome.;Inclusion criteria: The patients who meet the criteria of primary sjogren syndrome.;Inclusion criteria: The patients who meet the criteria of primary sjogren syndrome.;Inclusion criteria: The patients who meet the criteria of primary sjogren syndrome.

Exclusion criteria

Exclusion criteria: The patients who are pregnant, who has malignant tumor, who has other autoimmune diseases.;Exclusion criteria: The patients who are pregnant, who has malignant tumor, who has other autoimmune diseases.;Exclusion criteria: The patients who are pregnant, who has malignant tumor, who has other autoimmune diseases.;Exclusion criteria: The patients who are pregnant, who has malignant tumor, who has other autoimmune diseases.;Exclusion criteria: The patients who are pregnant, who has malignant tumor, who has other autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
B cell activating factor;

Countries

China

Contacts

Public ContactQian Wang;Qian Wang;Qian Wang;Qian Wang;Qian Wang ;;;;

Shanghai sixth people's hospital ;Shanghai sixth people's hospital ;Shanghai sixth people's hospital ;Shanghai sixth people's hospital ;Shanghai sixth people's hospital

wangqian198886@163.com;wangqian198886@163.com;wangqian198886@163.com;wangqian198886@163.com;wangqian198886@163.com+86 15601918612;+86 15601918612;+86 15601918612;+86 15601918612;+86 15601918612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026